The largest database of trusted experimental protocols

Ovalbumin ova type 6

Manufactured by Merck Group
Sourced in United States

Ovalbumin; OVA; type VI is a laboratory product sourced from chicken egg white. It is a widely used protein for various research and development applications.

Automatically generated - may contain errors

2 protocols using ovalbumin ova type 6

1

Sulfated Lactosyl Archaeol Lipid Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sulfated lactosyl archaeol (SLA; 6′-sulfate-β-D-Galp-(1,4)-β-D-Glcp-(1,1)-archaeol) was synthesized, as described previously [20 ]. Cy5.5-OVA conjugate was purchased from Nanocs (New York, NY, USA), while CellVueTM NIR815 was purchased from Thermofisher Scientific (Waltham, MA, USA).
Thin-film hydration archaeosomes were prepared, as previously described [10 (link)]. In brief, SLA lipid that was dissolved in chloroform/methanol underwent solvent removal under N2 gas with mild heating to form a thin lipid film. Dried lipids were then hydrated in Milli-Q water for more than 12 h to form a uniform lipid suspension. Next, sonication was applied at 40 °C in an ultrasonic water bath (Fisher Scientific, Ottawa, ON, Canada) for up to an hour until the desired particle size (~100 nm) was obtained. After that, 10 × PBS (Millipore Sigma Canada, Oakville, Ontario) was added and archaeosomes stored at 2–8 °C until used. Note that we have previously demonstrated that archaeosomes stored under similar conditions were stable up to 6 months of testing, which was well beyond the storage time of ~1 month in the current study [21 (link)]. On the day of immunization, antigen solution (ovalbumin; OVA; type VI, Sigma-Aldrich, St. Louis, MO, USA) was added to the pre-formed archaeosomes to reach a desired final concentration.
+ Open protocol
+ Expand
2

Archaeosome-Adjuvanted Antigen Immunization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female C56BL/6 mice (6 – 8 weeks; n = 6/gp) were injected subcutaneously (SC) on days 0 and 21 with 20 µg ovalbumin (OVA; type VI, Sigma-Aldrich) entrapped in archaeosomes of various compositions. In separate experiments, mice (n = 6/gp) were injected SC on days 0, 25 and 60 with 15 µg TRP-2180–188 entrapped in archaeosomes of various compositions as outlined in Table 1. Antigen with no adjuvant and non-immunized mice were included as negative controls. All animal experiments were repeated on at least one independent occasion to ensure reproducibility of results.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!